Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.40 |
| ▸ | PGR | P06401 | 3/20 | 0.40 |
| ▸ | NR3C2 | P08235 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | SYK | P43405 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL810967 | 0.83 | ALDH1A1 (0.50) | ALDH1A1LMNANPSR1SYKSMN1; SMN2 | |
| SCHEMBL5433387 | 0.81 | ALDH1A1 (0.52) | MMP2MMP8MMP13ALDH1A1LMNA | |
| SCHEMBL5418695 | 0.81 | ALDH1A1 (0.52) | MMP2MMP8MMP13ALDH1A1LMNA | |
| SCHEMBL810645 | 0.81 | ALDH1A1 (0.35) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL5422602 | 0.81 | TAS1R3 (0.38) | ALDH1A1EPHX2LMNASYKSMN1; SMN2 | |
| SCHEMBL5415725 | 0.81 | TAS1R3 (0.38) | ALDH1A1EPHX2LMNASYKSMN1; SMN2 | |
| SCHEMBL5430997 | 0.78 | ALDH1A1 (0.56) | ALDH1A1LMNANPSR1SMN1; SMN2TP53 | |
| SCHEMBL5422894 | 0.78 | ALDH1A1 (0.56) | ALDH1A1LMNANPSR1SMN1; SMN2TP53 | |
| SCHEMBL5422332 | 0.78 | SYK (0.41) | ALDH1A1LMNANPSR1SYKSMN1; SMN2 | |
| SCHEMBL5416681 | 0.78 | SYK (0.41) | ALDH1A1LMNANPSR1SYKSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2399895-B1 | Process for producing optically active aliphatic fluoroalcohol | KANTO KAGAKU (JP) | 2018-08-08 | — | — | EP | disclosed |
| US-9162934-B2 | Process for producing optically active alcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2015-10-20 | — | — | US | disclosed |
| EP-2394977-B1 | Process for producing optically active alcohol | KANTO KAGAKU (JP) | 2014-01-08 | — | — | EP | disclosed |
| US-8558033-B2 | Process for producing optically active aliphatic fluoroalcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2013-10-15 | — | — | US | disclosed |
| US-20110319671-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALIPHATIC FLUOROALCOHOL | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2011-12-29 | — | — | US | disclosed |
| EP-2399895-A2 | Process for producing optically active aliphatic fluoroalcohol | Kanto Kagaku Kabushiki Kaisha (JP) | 2011-12-28 | — | — | EP | disclosed |
| EP-2394977-A1 | Process for producing optically active alcohol | Kanto Kagaku Kabushiki Kaisha (JP) | 2011-12-14 | — | — | EP | disclosed |
| US-20110282077-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2011-11-17 | — | — | US | disclosed |
| US-7268250-B2 | Process for producing optically active compound | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2007-09-11 | — | — | US | disclosed |
| EP-1439159-B1 | Process for producing optically active compound | KANTO KAGAKU (JP) | 2007-06-20 | — | — | EP | disclosed |
| US-20040176616-A1 | Process for producing optically active compound | KANTO KAGAKU KABUSHIKI KAISHA | 2004-09-09 | — | — | US | disclosed |
| EP-1439159-A1 | Process for producing optically active compound | Kanto Kagaku Kabushiki Kaisha (JP) | 2004-07-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176616-A1 | Process for producing optically active compound | OSTC, NPEPPS, PPOX | CA1 3565/4885CA2 1764/4885MMP1 4117/4885 |
| US-20110282077-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | ADH1A, ADH1C, ADH5 | CA1 1041/4885CA2 713/4885MMP1 2634/4885 |
| US-20110319671-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALIPHATIC FLUOROALCOHOL | ADH1A, ADH1C, ADH5 | CA1 1136/4885CA2 1832/4885MMP1 1539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.